Clinical Trials Browser

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT05178628 2022-03-29

imPaCT-PRO

Phase 3 Unknown

450 enrolled

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT05067153 2021-10-05

TOP-RCT

Phase 4 Unknown

100 enrolled

Gastrointestinal

Esophageal Neoplasms, Thromboembolism, Thrombosis

NCT03893461 2021-07-22

CISTRON

Unknown

110 enrolled

Thoracic

Lung Neoplasms, Thromboembolism

NCT04246073 2020-07-31

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Unknown

400 enrolled

Neoplasms, Thromboembolism

NCT00982514 2012-09-12

Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008

Unknown

60 enrolled

LymphoidOther hematologic neoplasm

Thromboembolism, Thrombosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00400504 2006-11-17

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Unknown

500 enrolled

Neoplasms, Thromboembolism, Thrombophilia

Clinical Trials

CAT_PB

imPaCT-PRO

TOP-RCT

CISTRON

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)